Breast Cancer Clinical Trial

Breast MRI as a Preoperative Tool for DCIS

Summary

Breast MRI is a fairly new technology, but it has been well studied. It is now used routinely in many patients with breast cancer. It has been shown to be useful in detecting areas of cancer that cannot be seen using other types of scans or tests.

The purpose of this study is to see how often MRI can find other areas of cancer in women with one area of breast cancer, and to determine how having the MRI test affects their treatment. The purpose is also to study any areas of abnormality seen on your MRI with special methods that allow the images of your breast tissue and the microscopic analysis of your breast tissue to be compared very carefully. The study also aims to follow women who enter the study over a 10-year period to determine how often the breast cancer comes back.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Age less than 60 at time of consent
Clinical stage is consistent with Stage 0 or Stage I T1mic at presentation
Core biopsy proven DCIS or DCIS with microinvasion (invasion ≤0.1 cm), prior to enrollment
Breast surgery to be performed at MSKCC
Informed consent obtained
Female

Exclusion Criteria:

Age 60 or over at time of consent
Patients who are pregnant or nursing
Patients with contraindications to breast conservation
Excisional biopsy of DCIS or DCIS with microinvasion, prior to enrollment
Patients with any contraindications to MRI including pacemaker, tissue expander, other metallic surgical implants, weight over 350 lb., previous gadolinium reaction, metal fragments in eye

Study is for people with:

Breast Cancer

Estimated Enrollment:

115

Study ID:

NCT00605982

Recruitment Status:

Active, not recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

Memoral Sloan Kettering Cancer Center
Basking Ridge New Jersey, , United States
Memorial Sloan Kettering Cancer Center
Commack New York, 11725, United States
Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

115

Study ID:

NCT00605982

Recruitment Status:

Active, not recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider